ArchPoint Investors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.22M | Buy |
25,454
+289
| +1% | +$67.3K | 1.48% | 19 |
|
|
2025
Q4 | $5.21M | Hold |
25,165
| – | – | 1.24% | 20 |
|
|
2025
Q3 | $4.67M | Hold |
25,165
| – | – | 1.28% | 19 |
|
|
2025
Q2 | $3.84M | Buy |
+25,165
| New | +$3.87M | 1.13% | 20 |
|
|
2021
Q4 | – | Sell |
-3,778
| Closed | -$610K | – | 90 |
|
|
2021
Q3 | $610K | Buy |
+3,778
| New | +$645K | 0.18% | 49 |
|
|
2021
Q2 | – | Sell |
-6,208
| Closed | -$1.02M | – | 76 |
|
|
2021
Q1 | $1.02M | Sell |
6,208
-15
| -0.2% | -$2.43K | 0.29% | 54 |
|
|
2020
Q4 | $979K | Hold |
6,223
| – | – | 0.27% | 57 |
|
|
2020
Q3 | $926K | Buy |
6,223
+313
| +5% | +$46.3K | 0.3% | 42 |
|
|
2020
Q2 | $831K | Buy |
5,910
+1,045
| +21% | +$152K | 0.27% | 35 |
|
|
2020
Q1 | $638K | Buy |
4,865
+2,095
| +76% | +$297K | 0.25% | 43 |
|
|
2019
Q4 | $404K | Buy |
2,770
+2,605
| +1,579% | +$353K | 0.12% | 77 |
|
|
2019
Q3 | $21K | Hold |
165
| – | – | 0.01% | 127 |
|
|
2019
Q2 | $23K | Hold |
165
| – | – | 0.01% | 125 |
|
|
2019
Q1 | $23K | Hold |
165
| – | – | 0.01% | 127 |
|
|
2018
Q4 | $21K | Hold |
165
| – | – | 0.01% | 107 |
|
|
2018
Q3 | $23K | Hold |
165
| – | – | 0.01% | 127 |
|
|
2018
Q2 | $20K | Hold |
165
| – | – | 0.01% | 132 |
|
|
2018
Q1 | $21K | Hold |
165
| – | – | 0.01% | 151 |
|
|
2017
Q4 | $23K | Hold |
165
| – | – | 0.01% | 136 |
|
|
2017
Q3 | $21K | Hold |
165
| – | – | 0.01% | 146 |
|
|
2017
Q2 | $22K | Hold |
165
| – | – | 0.01% | 146 |
|
|
2017
Q1 | $20K | Buy |
+165
| New | +$19.7K | 0.01% | 136 |
|
|
2016
Q3 | – | Sell |
-165
| Closed | -$20K | – | 122 |
|
|
2016
Q2 | $20K | Hold |
165
| – | – | 0.01% | 122 |
|
|
2016
Q1 | $18K | Hold |
165
| – | – | 0.01% | 115 |
|
|
2015
Q4 | $17K | Buy |
+165
| New | +$16.6K | 0.01% | 121 |
|
|
2015
Q3 | – | Sell |
-14,825
| Closed | -$1.45M | – | 137 |
|
|
2015
Q2 | $1.45M | Hold |
14,825
| – | – | 0.9% | 27 |
|
|
2015
Q1 | $1.49M | Hold |
14,825
| – | – | 1.02% | 25 |
|
|
2014
Q4 | $1.55M | Sell |
14,825
-160
| -1% | -$16.9K | 1.15% | 26 |
|
|
2014
Q3 | $1.6M | Sell |
14,985
-100
| -0.7% | -$10.4K | 1.35% | 22 |
|
|
2014
Q2 | $1.58M | Sell |
15,085
-575
| -4% | -$58.1K | 1.33% | 24 |
|
|
2014
Q1 | $1.54M | Buy |
15,660
+300
| +2% | +$27.8K | 1.39% | 22 |
|
|
2013
Q4 | $1.41M | Hold |
15,360
| – | – | 1.28% | 21 |
|
|
2013
Q3 | $1.33M | Sell |
15,360
-40
| -0.3% | -$3.59K | 1.47% | 21 |
|
|
2013
Q2 | $1.32M | Buy |
+15,400
| New | +$1.31M | 1.56% | 19 |
|
Other funds holding JNJ
VCM
VPM
ArchPoint Investors's JNJ Position: Q1 2026 in Review
ArchPoint Investors increased its Johnson & Johnson (JNJ) stake by 1.1% in Q1 2026, buying an estimated $67.3K and bringing the position to 25,454 shares worth $6.22M. The position accounts for 1.48% of the portfolio, ranked #19.
ArchPoint Investors first reported a position in JNJ in Q2 2013 and has held it in 34 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- ArchPoint Investors held 25,454 shares of Johnson & Johnson worth $6.22M as of Q1 2026.
- ArchPoint Investors bought 289 Johnson & Johnson shares in Q1 2026, an estimated $67.3K.
- Johnson & Johnson made up 1.48% of ArchPoint Investors's portfolio in Q1 2026, its #19 holding.
- ArchPoint Investors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 34 quarters since.
- 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on ArchPoint Investors's 13F filing for Q1 2026, filed 14 May 2026.